FDA approves a third drug for a rare joint tumour
The FDA has approved pimicotinib, sold as Pimjetmi, for tenosynovial giant cell tumour. This rare, non-cancerous tumour grows in joints and mostly hits younger adults. The pill is for patients where surgery could make things worse. In a trial of 94 people, tumours shrank in 54% of those on the drug and 3% on a dummy pill.
Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.